Washed Microbiota Transplantation Improves Patients with Overweight by the Gut Microbiota and Sphingolipid Metabolism
-
Published:2023-08-29
Issue:9
Volume:11
Page:2415
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Wu Lei123ORCID, Lin Zi-Han1, Lu Xin-Jian1, Hu Xuan1, Zhong Hao-Jie1ORCID, Lin De-Jiang1, Liu Tao1, Xu Jia-Ting1, Lin Wen-Ying1, Wu Qing-Ping2ORCID, He Xing-Xiang1ORCID
Affiliation:
1. Department of Gastroenterology, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China 2. Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China 3. School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China
Abstract
Background: Overweight (OW) and obesity have become increasingly serious public health problems worldwide. The clinical impact of washed microbiota transplantation (WMT) from healthy donors in OW patients is unclear. This study aimed to investigate the effect of WMT in OW patients. Methods: The changes in body mass index (BMI = weight (kg)/height (m)2), blood glucose, blood lipids and other indicators before and after WMT were compared. At the same time, 16S rRNA gene amplicon sequencing was performed on fecal samples of OW patients before and after transplantation. Finally, serum samples were tested for sphingolipids targeted by lipid metabolomics. Results: A total of 166 patients were included, including 52 in the OW group and 114 in the normal weight (NOW) group. For OW patients, WMT significantly improved the comprehensive efficacy of OW. In the short term (about 1 month) and medium term (about 2 months), a significant reduction in BMI was seen. At the same time, in the short term (about 1 month), liver fat attenuation (LFA), triglyceride (TG) and fasting blood glucose (FBG) were significantly reduced. In the long term (about 5 months), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), non-high-density lipoprotein (non-HDL-c), etc. were significantly reduced. WMT improved the gut microbiota of OW patients, and also had an improvement effect on OW patients by regulating sphingolipid metabolism. Conclusion: WMT had a significant improvement effect on OW patients. WMT could restore gut microbiota homeostasis and improve OW patients by regulating sphingolipid metabolism.
Funder
Key-Area Research and Development Program of Guangdong Province Medical Scientific Research Foundation of Guangdong Province Scientific Research Projects of Guangdong Bureau of Traditional Chinese Medicine Guangdong Innovation Research Team for Higher Education
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference43 articles.
1. GBD 2015 Obesity Collaborators, Afshin, A., Forouzanfar, M.H., Reitsma, M.B., Sur, P., Estep, K., Lee, A., Marczak, L., Mokdad, A.H., and Moradi-Lakeh, M. (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med., 377, 13–27. 2. The Global Epidemic of the Metabolic Syndrome;Saklayen;Curr. Hypertens. Rep.,2018 3. Metabolic Syndrome Pathophysiology and Predisposing Factors;Bovolini;Int. J. Sports Med.,2021 4. Sphingolipids in Inflammation;Albi;Mediat. Inflamm.,2018 5. Ceramides—Lipotoxic Inducers of Metabolic Disorders;Chaurasia;Trends Endocrinol. Metab.,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|